Corrigendum to "Synthesis and in vitro pharmacological studies of new C(4) modified salvinorin A analogues" [Bioorg. Med. Chem. Lett. 16 (2006) 5498-5502] (DOI:10.1016/j.bmcl.2006.08.051);Synthesis and in vitro pharmacological studies of new C(4)-modified salvinorin A analogues

Bioorganic and Medicinal Chemistry Letters

Volumn 16, Issue 21, 2006, Pages 5498-5502

  Lee, David Y W ^a   He, Minsheng ^a   Liu Chen, Lee Yuan ^b   Wang, Yulin ^b   Li, Jian Guo ^b   Xu, Wei ^b   Ma, Zhongze ^a   Carlezon Jr , William A ^a   Cohen, Bruce ^a  

^a MCLEAN HOSPITAL   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Agonist; Noclerodane diterpene; Salvinorin; Opioid receptor

Indexed keywords

KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR AGONIST; SALVINORIN A;

ARTICLE; DRUG ACTIVITY; DRUG ISOLATION; DRUG RECEPTOR BINDING; DRUG SCREENING; DRUG SYNTHESIS; IN VITRO STUDY; REDUCTION; STRUCTURE ACTIVITY RELATION;

SALVIA DIVINORUM;

EID: 33748762287     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2008.02.005     Document Type: Erratum

References (34)

1. Liu-Chen L.-Y. Life Sci. 75 (2004) 511
2. Simonin F., Valverde O., Smadja C., Slowe S., Kitchen I., Dierich A., Le M., Roques B.P., Maldonado R., and Kieffer B.L. EMBO J. 17 (1998) 886
3. Ghozland S., Matthes H.W., Simonin F., Filliol D., Kieffer B.L., and Maldonado R. J. Neurosci. 22 (2002) 1146
4. Von Voigtlander P.F., Lahti R.A., and Ludens J.H. J. Pharmacol. Exp. Ther. 224 (1983) 7
5. Szmuszkovicz J. Prog. Drug Res. 53 (1999) 1
6. Mague S.D., Pliakas A.M., Todtenkopf M.S., Tomasiewicz H.C., Zhang Y., Stevens Jr. W.C., Jones R.M., Portoghese P.S., and Carlezon Jr. W.A. J. Pharmacol. Exp. Ther. 305 (2003) 323
7. Todtenkopf M.S., Marcus J.F., Portoghese P.S., and Carlezon Jr. W.A. Psychopharmacology 172 (2004) 463
8. Pfeiffer A., Brantl V., Herz A., and Emrich H.M. Science 233 (1986) 774
9. Walsh S.L., Strain E.C., Abreu M.E., and Bigelow G.E. Psychopharmacology 157 (2001) 151
10. Nagase H., Hayakawa J., Kawamura K., Kawai K., Takezawa Y., Matsuura H., Tajima C., and Endo T. Chem. Pharm. Bull. 46 (1998) 366
11. Togashi Y., Umeuchi H., Okano K., Ando N., Yoshizawa Y., Honda T., Kawamura K., Endoh T., Utsumi J., Kamei J., Tanaka T., and Nagase H. Eur. J. Pharmacol. 435 (2002) 259
12. Roth B.L., Baner K., Westkaemper R., Siebert D.J., Rice K.C., Steinberg S., Ernsberger P., and Rothman R.B. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 11934
13. Sheffler D.J., and Roth B.L. Trends Pharmacol. Sci. 24 (2003) 107
14. Chavkin C., Sub S., Jin W., Stewart J., Zjawiony J.K., Siebert D.J., Toth B.A., Hufeisen S.J., and Roth B.L. J. Pharmacol. Exp. Ther. 308 (2004) 1197
15. Wang Y., Tang K., Inan S., Siebert D., Holzgrabe U., Lee D.Y.W., Huang P., Li J.G., Cowan A., and Liu-Chen L.-Y. J. Pharmacol. Exp. Ther. 312 (2005) 220
16. Valdes III L.J., Diaz J.L., and Paul A.G. J. Ethnopharmacol. 7 (1983) 287
17. Valdés III L.J. J. Psychoactive Drugs 26 (1994) 277
18. Mowry M., Mosher M., and Briner W.J. Psychoactive Drugs 35 (2003) 379
19. Hanes K.R. J. Clin. Psychopharmacol. 21 (2001) 634
20. Butelman E.R., Harris T.J., and Kreek M. J. Psychopharmacol. 172 (2004) 220
21. Lee D.Y.W., Karnati V.V.R., He M., Liu-Chen L.-Y., Kondaveti L., Ma Z., Wang Y., Chen Y., Beguin C., Carlezon W.A., and Cohen B.M. Bioorg. Med. Chem. Lett. (2005) 3744
22. Lee D.Y.W., He M., Kondaveti L., Liu-Chen L.-Y., Ma Z., Wang Y., Chen Y., Li J., Beguin C., Carlezon W.A., and Cohen B.M. Bioorg. Med. Chem. Lett. (2005) 4169
23. Beguin C., Richards M., Wang Y., Chen Y., Liu-Chen L.-Y., Ma Z., Lee D.Y.W., Carlezon W.A., and Cohen B.M. Bioorg. Med. Chem. Lett. 15 (2005) 2761
24. Lee D.Y.W., Ma Z., Liu-Chen L.-Y., Wang Y., Chen Y., Carlezon W.A., and Cohen B.M. Bioorg. Med. Chem. (2005) 5635
25. Munro T.A., Rizzacasa M.A., Roth B.L., Toth B.A., and Yan F. J. Med. Chem. 48 (2005) 345
26. Yoon N.M., and Pak C.S. J. Org. Chem. 88 (1973) 2786
27. Dondoni A., and Perrone D. Org. Syn. 77 (2000) 64
28. Greene A.E., Drian C.L., and Crabbe P. J. Am. Chem. Soc. 102 (1980) 7583
29. Dhaon M.K., Olsen R.K., and Ramasamy K. J. Org. Chem. 47 (1982) 1962
30. Meyers A.I., and Reider P.J. J. Am. Chem. Soc. 101 (1979) 2501
31. Duncia J.V., Pierce M.E., and Santella J.B. J. Org. Chem. 56 (1991) 2395
32. Kitajima M., Yokoya M., Takayama H., and Aimi N. Chem. Pharm. Bull. 50 (2002) 1376
33. Wang Y., Tang K., Inan S., Siebert D., Holzgrabe U., Lee D.Y., Huang P., Li J.G., Cowan A., and Liu-Chen L.Y. J. Pharmacol. Exp. Ther. 312 (2005) 220
34. 3): 202.0, 199.8, 173.7, 169.9, 144.1, 140.0, 123.3, 108.5, 75.8, 70.3, 64.1, 59.2, 48.3, 45.7, 42.9, 35.0, 34.2, 28.6, 24.7, 20.9, 18.0, 16.9.